{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:29:43Z","timestamp":1789831783390,"version":"4.0.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the promotion of science","doi-asserted-by":"publisher","award":["24K02475"],"award-info":[{"award-number":["24K02475"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K19549"],"award-info":[{"award-number":["25K19549"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12185-026-04177-3","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:22:14Z","timestamp":1770974534000},"page":"792-801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in the pathophysiology of acute and chronic graft-versus-host disease"],"prefix":"10.1007","volume":"123","author":[{"given":"Shuichiro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-9704","authenticated-orcid":false,"given":"Daigo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"9674","key":"4177_CR1","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(09)60237-3.","journal-title":"Lancet"},{"key":"4177_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00439","volume":"7","author":"P Apostolova","year":"2016","unstructured":"Apostolova P, Zeiser R. The role of purine metabolites as DAMPs in acute graft-versus-host disease. Front Immunol. 2016;7:439. https:\/\/doi.org\/10.3389\/fimmu.2016.00439.","journal-title":"Front Immunol"},{"issue":"5426","key":"4177_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1126\/science.285.5426.412","volume":"285","author":"WD Shlomchik","year":"1999","unstructured":"Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Sci. 1999;285(5426):412\u20135. https:\/\/doi.org\/10.1126\/science.285.5426.412.","journal-title":"Sci"},{"key":"4177_CR4","doi-asserted-by":"publisher","unstructured":"Koyama M, Mukhopadhyay P, Schuster IS, Henden AS, Hulsdunker J, Varelias A et al. MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. Immunity. 2019 51(5):885\u201398 e7. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.011.","DOI":"10.1016\/j.immuni.2019.08.011"},{"issue":"24","key":"4177_CR5","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood.2019000823","volume":"134","author":"M Koyama","year":"2019","unstructured":"Koyama M, Hill GR. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease. Blood. 2019;134(24):2139\u201348. https:\/\/doi.org\/10.1182\/blood.2019000823.","journal-title":"Blood"},{"issue":"1","key":"4177_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296\u2013307. https:\/\/doi.org\/10.1182\/blood-2011-06-364265.","journal-title":"Blood"},{"issue":"1","key":"4177_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","volume":"112","author":"BE Anderson","year":"2003","unstructured":"Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112(1):101\u20138. https:\/\/doi.org\/10.1172\/JCI17601.","journal-title":"J Clin Invest"},{"issue":"11","key":"4177_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.21.01755","volume":"40","author":"M Bleakley","year":"2022","unstructured":"Bleakley M, Sehgal A, Seropian S, Biernacki MA, Krakow EF, Dahlberg A, et al. Naive T-cell depletion to prevent chronic Graft-Versus-Host Disease. J Clin Oncol. 2022;40(11):1174\u201385. https:\/\/doi.org\/10.1200\/JCO.21.01755.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4177_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.immuni.2019.06.003","volume":"51","author":"YY Fu","year":"2019","unstructured":"Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, et al. T cell recruitment to the intestinal stem cell compartment drives immune-mediated intestinal damage after allogeneic transplantation. Immunity. 2019;51(1):90-103 e3. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.003.","journal-title":"Immunity"},{"issue":"8","key":"4177_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/s41591-024-03016-4","volume":"30","author":"YB Chen","year":"2024","unstructured":"Chen YB, Mohty M, Zeiser R, Teshima T, Jamy O, Maertens J, et al. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nat Med. 2024;30(8):2277\u201387. https:\/\/doi.org\/10.1038\/s41591-024-03016-4.","journal-title":"Nat Med"},{"issue":"9","key":"4177_CR11","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","volume":"95","author":"GR Hill","year":"2000","unstructured":"Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95(9):2754\u20139.","journal-title":"Blood"},{"issue":"6","key":"4177_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nm0602-575","volume":"8","author":"T Teshima","year":"2002","unstructured":"Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575\u201381. https:\/\/doi.org\/10.1038\/nm0602-575.","journal-title":"Nat Med"},{"issue":"24","key":"4177_CR13","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1182\/blood-2013-12-543736","volume":"123","author":"S Spoerl","year":"2014","unstructured":"Spoerl S, Mathew NR, Bscheider M, Schmitt-Graeff A, Chen S, Mueller T, et al. Activity of therapeutic JAK 1\/2 blockade in graft-versus-host disease. Blood. 2014;123(24):3832\u201342. https:\/\/doi.org\/10.1182\/blood-2013-12-543736.","journal-title":"Blood"},{"issue":"19","key":"4177_CR14","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800\u201310. https:\/\/doi.org\/10.1056\/NEJMoa1917635.","journal-title":"N Engl J Med"},{"issue":"13","key":"4177_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1182\/blood-2016-09-740431","volume":"129","author":"SR Wu","year":"2017","unstructured":"Wu SR, Reddy P. Tissue tolerance: a distinct concept to control acute GVHD severity. Blood. 2017;129(13):1747\u201352. https:\/\/doi.org\/10.1182\/blood-2016-09-740431.","journal-title":"Blood"},{"issue":"2","key":"4177_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1084\/jem.20101559","volume":"208","author":"S Takashima","year":"2011","unstructured":"Takashima S, Kadowaki M, Aoyama K, Koyama M, Oshima T, Tomizuka K, et al. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells. J Exp Med. 2011;208(2):285\u201394. https:\/\/doi.org\/10.1084\/jem.20101559.","journal-title":"J Exp Med"},{"issue":"2","key":"4177_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash AM, Dudakov JA, Hua G, O\u2019Connor MH, Young LF, Singer NV, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 2012;37(2):339\u201350. https:\/\/doi.org\/10.1016\/j.immuni.2012.05.028.","journal-title":"Immunity"},{"issue":"18","key":"4177_CR18","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2017-06-792614","volume":"131","author":"S Takahashi","year":"2018","unstructured":"Takahashi S, Hashimoto D, Hayase E, Ogasawara R, Ohigashi H, Ara T, et al. Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease. Blood. 2018;131(18):2074\u201385. https:\/\/doi.org\/10.1182\/blood-2017-06-792614.","journal-title":"Blood"},{"issue":"8","key":"4177_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2023023060","volume":"144","author":"Y Hasegawa","year":"2024","unstructured":"Hasegawa Y, Hashimoto D, Zhang Z, Miyajima T, Saito Y, Li W, et al. GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Blood. 2024;144(8):904\u201313. https:\/\/doi.org\/10.1182\/blood.2023023060.","journal-title":"Blood"},{"issue":"2","key":"4177_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2013.11.008","volume":"14","author":"C Metcalfe","year":"2014","unstructured":"Metcalfe C, Kljavin NM, Ybarra R, de Sauvage FJ. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell. 2014;14(2):149\u201359. https:\/\/doi.org\/10.1016\/j.stem.2013.11.008.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"4177_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1182\/blood.2021015111","volume":"141","author":"DM Ponce","year":"2023","unstructured":"Ponce DM, Alousi AM, Nakamura R, Slingerland J, Calafiore M, Sandhu KS, et al. A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract. Blood. 2023;141(12):1389\u2013401. https:\/\/doi.org\/10.1182\/blood.2021015111.","journal-title":"Blood"},{"issue":"12","key":"4177_CR22","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood.2020005957","volume":"136","author":"J Norona","year":"2020","unstructured":"Norona J, Apostolova P, Schmidt D, Ihlemann R, Reischmann N, Taylor G, et al. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. Blood. 2020;136(12):1442\u201355. https:\/\/doi.org\/10.1182\/blood.2020005957.","journal-title":"Blood"},{"key":"4177_CR23","doi-asserted-by":"publisher","unstructured":"Ramos KN, Leino D, Luebbering N, Grimley MS, Badia P, Davies SM et al. Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults. Transplant Cell Ther. 2024 30(4):454 e1- e6. https:\/\/doi.org\/10.1016\/j.jtct.2024.01.080.","DOI":"10.1016\/j.jtct.2024.01.080"},{"issue":"34","key":"4177_CR24","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","volume":"112","author":"LA Monticelli","year":"2015","unstructured":"Monticelli LA, Osborne LC, Noti M, Tran SV, Zaiss DM, Artis D. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci. 2015;112(34):10762\u20137. https:\/\/doi.org\/10.1073\/pnas.1509070112.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"4177_CR25","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1800003","volume":"201","author":"F Chen","year":"2018","unstructured":"Chen F, Yang W, Huang X, Cao AT, Bilotta AJ, Xiao Y, et al. Neutrophils promote amphiregulin production in intestinal epithelial cells through TGF-\u03b2 and contribute to intestinal homeostasis. J Immunol. 2018;201(8):2492\u2013501. https:\/\/doi.org\/10.4049\/jimmunol.1800003.","journal-title":"J Immunol"},{"issue":"2","key":"4177_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jnci\/52.2.401","volume":"52","author":"DW van Bekkum","year":"1974","unstructured":"van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst. 1974;52(2):401\u20134. https:\/\/doi.org\/10.1093\/jnci\/52.2.401.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"4177_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.20112408","volume":"209","author":"RR Jenq","year":"2012","unstructured":"Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012;209(5):903\u201311. https:\/\/doi.org\/10.1084\/jem.20112408.","journal-title":"J Exp Med"},{"issue":"1","key":"4177_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1182\/blood-2011-12-401166","volume":"120","author":"Y Eriguchi","year":"2012","unstructured":"Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of \u03b1-defensins. Blood. 2012;120(1):223\u201331. https:\/\/doi.org\/10.1182\/blood-2011-12-401166.","journal-title":"Blood"},{"issue":"9","key":"4177_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1900623.","journal-title":"N Engl J Med"},{"issue":"339","key":"4177_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2311","volume":"8","author":"Y Shono","year":"2016","unstructured":"Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8(339):339ra71. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2311.","journal-title":"Sci Transl Med"},{"key":"4177_CR31","doi-asserted-by":"publisher","unstructured":"Hayase E, Hayase T, Jamal MA, Miyama T, Chang CC, Ortega MR et al. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell. 2022 185(20):3705\u201319 e14. https:\/\/doi.org\/10.1016\/j.cell.2022.09.007.","DOI":"10.1016\/j.cell.2022.09.007"},{"key":"4177_CR32","doi-asserted-by":"publisher","unstructured":"Hayase E, Hayase T, Mukherjee A, Stinson SC, Jamal MA, Ortega MR et al. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 32(9):1621\u201336 e6. https:\/\/doi.org\/10.1016\/j.chom.2024.08.004.","DOI":"10.1016\/j.chom.2024.08.004"},{"issue":"6469","key":"4177_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.aax3760","volume":"366","author":"CK Stein-Thoeringer","year":"2019","unstructured":"Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Sci. 2019;366(6469):1143\u20139. https:\/\/doi.org\/10.1126\/science.aax3760.","journal-title":"Sci"},{"issue":"8023","key":"4177_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-024-07667-8","volume":"632","author":"K Fujimoto","year":"2024","unstructured":"Fujimoto K, Hayashi T, Yamamoto M, Sato N, Shimohigoshi M, Miyaoka D, et al. An enterococcal phage-derived enzyme suppresses graft-versus-host disease. Nat. 2024;632(8023):174\u201381. https:\/\/doi.org\/10.1038\/s41586-024-07667-8.","journal-title":"Nat"},{"key":"4177_CR35","doi-asserted-by":"publisher","unstructured":"Ladas EJ, Collier W, Park H, Auletta JJ, Dvorak CC, August A et al. A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report from the Children\u2019s Oncology Group (ACCL1633). Transplant Cell Ther. 2025 31(7):452 e1- e12. https:\/\/doi.org\/10.1016\/j.jtct.2025.04.009.","DOI":"10.1016\/j.jtct.2025.04.009"},{"key":"4177_CR36","doi-asserted-by":"publisher","unstructured":"Gorshein E, Wei C, Ambrosy S, Budney S, Vivas J, Shenkerman A et al. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2017;31(5). https:\/\/doi.org\/10.1111\/ctr.12947.","DOI":"10.1111\/ctr.12947"},{"issue":"19","key":"4177_CR37","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1182\/bloodadvances.2020002604","volume":"4","author":"K Yoshifuji","year":"2020","unstructured":"Yoshifuji K, Inamoto K, Kiridoshi Y, Takeshita K, Sasajima S, Shiraishi Y, et al. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020;4(19):4607\u201317. https:\/\/doi.org\/10.1182\/bloodadvances.2020002604.","journal-title":"Blood Adv"},{"key":"4177_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101836","volume":"78","author":"E Yazdandoust","year":"2023","unstructured":"Yazdandoust E, Hajifathali A, Roshandel E, Zarif MN, Pourfathollah AA, Parkhideh S, et al. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation. Transpl Immunol. 2023;78:101836. https:\/\/doi.org\/10.1016\/j.trim.2023.101836.","journal-title":"Transpl Immunol"},{"issue":"5","key":"4177_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17(5):505\u201313. https:\/\/doi.org\/10.1038\/ni.3400.","journal-title":"Nat Immunol"},{"issue":"6571","key":"4177_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh2444","volume":"374","author":"KAU Gonzales","year":"2021","unstructured":"Gonzales KAU, Polak L, Matos I, Tierney MT, Gola A, Wong E, et al. Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories. Sci. 2021;374(6571):eabh2444. https:\/\/doi.org\/10.1126\/science.abh2444.","journal-title":"Sci"},{"issue":"7677","key":"4177_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550(7677):475\u201380. https:\/\/doi.org\/10.1038\/nature24271.","journal-title":"Nature"},{"issue":"11","key":"4177_CR42","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood.2024028197","volume":"146","author":"D Zhao","year":"2025","unstructured":"Zhao D, Reddy P. Inflammatory memory of stem cells: implications for hematologic diseases. Blood. 2025;146(11):1265\u201375. https:\/\/doi.org\/10.1182\/blood.2024028197.","journal-title":"Blood"},{"issue":"7147","key":"4177_CR43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007;447(7147):972\u20138. https:\/\/doi.org\/10.1038\/nature05836.","journal-title":"Nature"},{"key":"4177_CR44","doi-asserted-by":"publisher","unstructured":"Larsen SB, Cowley CJ, Sajjath SM, Barrows D, Yang Y, Carroll TS et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell. 2021;28(10):1758\u201374 e8. https:\/\/doi.org\/10.1016\/j.stem.2021.07.001.","DOI":"10.1016\/j.stem.2021.07.001"},{"issue":"2","key":"4177_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jid.2010.280","volume":"131","author":"M Suarez-Farinas","year":"2011","unstructured":"Suarez-Farinas M, Fuentes-Duculan J, Lowes MA, Krueger JG. Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol. 2011;131(2):391\u2013400. https:\/\/doi.org\/10.1038\/jid.2010.280.","journal-title":"J Invest Dermatol"},{"issue":"7720","key":"4177_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41586-018-0449-8","volume":"560","author":"J Ordovas-Montanes","year":"2018","unstructured":"Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 2018;560(7720):649\u201354. https:\/\/doi.org\/10.1038\/s41586-018-0449-8.","journal-title":"Nature"},{"issue":"7847","key":"4177_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo D, Ho YJ, Burdziak C, Maag JLV, Morris JPt, Chandwani R, et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature. 2021;590(7847):642\u20138. https:\/\/doi.org\/10.1038\/s41586-020-03147-x.","journal-title":"Nature"},{"key":"4177_CR48","doi-asserted-by":"publisher","unstructured":"Zhao D, Ravikumar V, Leach TJ, Kraushaar D, Lauder E, Li L et al. Inflammation-induced epigenetic imprinting regulates intestinal stem cells. Cell Stem Cell. 2024;31(10):1447\u201364 e6. https:\/\/doi.org\/10.1016\/j.stem.2024.08.006.","DOI":"10.1016\/j.stem.2024.08.006"},{"issue":"Supplement 1","key":"4177_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2024-202926","volume":"144","author":"T Miyajima","year":"2024","unstructured":"Miyajima T, Hashimoto D, Kojima K, Tsukamoto S, Ichiki T, Saito Y, et al. Gvhd-induced inflammatory memory in intestinal stem cells enhances IFN-\u03b3-induced antigen presentation and apoptosis of intestinal epithelial cells. Blood. 2024;144(Supplement 1):260.","journal-title":"Blood"},{"issue":"26","key":"4177_CR50","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377(26):2565\u201379. https:\/\/doi.org\/10.1056\/NEJMra1703472.","journal-title":"N Engl J Med"},{"issue":"1","key":"4177_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1182\/blood-2011-01-332478","volume":"119","author":"H Nishimori","year":"2012","unstructured":"Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, et al. Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood. 2012;119(1):285\u201395. https:\/\/doi.org\/10.1182\/blood-2011-01-332478.","journal-title":"Blood"},{"issue":"6","key":"4177_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/bloodadvances.2016002980","volume":"1","author":"KH Gartlan","year":"2017","unstructured":"Gartlan KH, Varelias A, Koyama M, Robb RJ, Markey KA, Chang K, et al. Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT. Blood Adv. 2017;1(6):341\u201351. https:\/\/doi.org\/10.1182\/bloodadvances.2016002980.","journal-title":"Blood Adv"},{"issue":"15","key":"4177_CR53","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2014-07-590232","volume":"125","author":"A Varelias","year":"2015","unstructured":"Varelias A, Gartlan KH, Kreijveld E, Olver SD, Lor M, Kuns RD, et al. Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood. 2015;125(15):2435\u201344. https:\/\/doi.org\/10.1182\/blood-2014-07-590232.","journal-title":"Blood"},{"issue":"25","key":"4177_CR54","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1182\/blood-2014-03-562231","volume":"123","author":"R Flynn","year":"2014","unstructured":"Flynn R, Du J, Veenstra RG, Reichenbach DK, Panoskaltsis-Mortari A, Taylor PA, et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood. 2014;123(25):3988\u201398. https:\/\/doi.org\/10.1182\/blood-2014-03-562231.","journal-title":"Blood"},{"issue":"20","key":"4177_CR55","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2015-12-688895","volume":"127","author":"E Forcade","year":"2016","unstructured":"Forcade E, Kim HT, Cutler C, Wang K, Alho AC, Nikiforow S, et al. Circulating T follicular helper cells with increased function during chronic graft-versus-host disease. Blood. 2016;127(20):2489\u201397. https:\/\/doi.org\/10.1182\/blood-2015-12-688895.","journal-title":"Blood"},{"issue":"1","key":"4177_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood-2007-01-071043","volume":"110","author":"S Svegliati","year":"2007","unstructured":"Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood. 2007;110(1):237\u201341. https:\/\/doi.org\/10.1182\/blood-2007-01-071043.","journal-title":"Blood"},{"issue":"13","key":"4177_CR57","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1182\/blood-2017-04-779934","volume":"131","author":"T Yamakawa","year":"2018","unstructured":"Yamakawa T, Ohigashi H, Hashimoto D, Hayase E, Takahashi S, Miyazaki M, et al. Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease. Blood. 2018;131(13):1476\u201385. https:\/\/doi.org\/10.1182\/blood-2017-04-779934.","journal-title":"Blood"},{"issue":"17","key":"4177_CR58","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","volume":"127","author":"R Flynn","year":"2016","unstructured":"Flynn R, Paz K, Du J, Reichenbach DK, Taylor PA, Panoskaltsis-Mortari A, et al. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 2016;127(17):2144\u201354. https:\/\/doi.org\/10.1182\/blood-2015-10-678706.","journal-title":"Blood"},{"issue":"22","key":"4177_CR59","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","volume":"138","author":"C Cutler","year":"2021","unstructured":"Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278\u201389. https:\/\/doi.org\/10.1182\/blood.2021012021.","journal-title":"Blood"},{"issue":"10","key":"4177_CR60","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1172\/JCI75935","volume":"124","author":"KA Alexander","year":"2014","unstructured":"Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. J Clin Invest. 2014;124(10):4266\u201380. https:\/\/doi.org\/10.1172\/JCI75935.","journal-title":"J Clin Invest"},{"issue":"11","key":"4177_CR61","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","volume":"391","author":"D Wolff","year":"2024","unstructured":"Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, et al. Axatilimab in recurrent or refractory chronic graft-versus-host disease. N Engl J Med. 2024;391(11):1002\u201314. https:\/\/doi.org\/10.1056\/NEJMoa2401537.","journal-title":"N Engl J Med"},{"key":"4177_CR62","doi-asserted-by":"publisher","unstructured":"Perry JSA, Russler-Germain EV, Zhou YW, Purtha W, Cooper ML, Choi J et al. Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance. Immunity. 2018 48(5):923\u201336 e4. https:\/\/doi.org\/10.1016\/j.immuni.2018.04.007.","DOI":"10.1016\/j.immuni.2018.04.007"},{"issue":"12","key":"4177_CR63","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1182\/blood-2004-12-4980","volume":"105","author":"E Tivol","year":"2005","unstructured":"Tivol E, Komorowski R, Drobyski WR. Emergent autoimmunity in graft-versus-host disease. Blood. 2005;105(12):4885\u201391. https:\/\/doi.org\/10.1182\/blood-2004-12-4980.","journal-title":"Blood"},{"issue":"4","key":"4177_CR64","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1182\/blood-2006-08-042853","volume":"109","author":"Y Sakoda","year":"2007","unstructured":"Sakoda Y, Hashimoto D, Asakura S, Takeuchi K, Harada M, Tanimoto M, et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood. 2007;109(4):1756\u201364. https:\/\/doi.org\/10.1182\/blood-2006-08-042853.","journal-title":"Blood"},{"issue":"26","key":"4177_CR65","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1182\/blood-2012-01-401596","volume":"119","author":"H Rangarajan","year":"2012","unstructured":"Rangarajan H, Yassai M, Subramanian H, Komorowski R, Whitaker M, Gorski J, et al. Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. Blood. 2012;119(26):6354\u201364. https:\/\/doi.org\/10.1182\/blood-2012-01-401596.","journal-title":"Blood"},{"issue":"16","key":"4177_CR66","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1073\/pnas.87.16.6301","volume":"87","author":"N Fukushi","year":"1990","unstructured":"Fukushi N, Arase H, Wang B, Ogasawara K, Gotohda T, Good RA, et al. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci U S A. 1990;87(16):6301\u20135. https:\/\/doi.org\/10.1073\/pnas.87.16.6301.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4177_CR67","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.178.3.805","volume":"178","author":"J Desbarats","year":"1993","unstructured":"Desbarats J, Lapp WS. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med. 1993;178(3):805\u201314. https:\/\/doi.org\/10.1084\/jem.178.3.805.","journal-title":"J Exp Med"},{"issue":"26","key":"4177_CR68","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1182\/blood-2009-11-253559","volume":"115","author":"Y Shono","year":"2010","unstructured":"Shono Y, Ueha S, Wang Y, Abe J, Kurachi M, Matsuno Y, et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood. 2010;115(26):5401\u201311. https:\/\/doi.org\/10.1182\/blood-2009-11-253559.","journal-title":"Blood"},{"issue":"4","key":"4177_CR69","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbmt.2013.12.568","volume":"20","author":"Y Shono","year":"2014","unstructured":"Shono Y, Shiratori S, Kosugi-Kanaya M, Ueha S, Sugita J, Shigematsu A, et al. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(4):495\u2013500. https:\/\/doi.org\/10.1016\/j.bbmt.2013.12.568.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"4177_CR70","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","volume":"113","author":"S Sarantopoulos","year":"2009","unstructured":"Sarantopoulos S, Stevenson KE, Kim HT, Cutler CS, Bhuiya NS, Schowalter M, et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood. 2009;113(16):3865\u201374. https:\/\/doi.org\/10.1182\/blood-2008-09-177840.","journal-title":"Blood"},{"issue":"20","key":"4177_CR71","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","volume":"13","author":"S Sarantopoulos","year":"2007","unstructured":"Sarantopoulos S, Stevenson KE, Kim HT, Bhuiya NS, Cutler CS, Soiffer RJ, et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res. 2007;13(20):6107\u201314. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1290.","journal-title":"Clin Cancer Res"},{"key":"4177_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.995149","volume":"13","author":"Y Jeon","year":"2022","unstructured":"Jeon Y, Lim JY, Im KI, Kim N, Cho SG. BAFF blockade attenuates acute graft-versus-host disease directly via the dual regulation of T- and B-cell homeostasis. Front Immunol. 2022;13:995149. https:\/\/doi.org\/10.3389\/fimmu.2022.995149.","journal-title":"Front Immunol"},{"issue":"26","key":"4177_CR73","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1182\/blood-2014-08-595470","volume":"125","author":"R Flynn","year":"2015","unstructured":"Flynn R, Allen JL, Luznik L, MacDonald KP, Paz K, Alexander KA, et al. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. Blood. 2015;125(26):4085\u201394. https:\/\/doi.org\/10.1182\/blood-2014-08-595470.","journal-title":"Blood"},{"issue":"5","key":"4177_CR74","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI41072","volume":"120","author":"K Matsuoka","year":"2010","unstructured":"Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010;120(5):1479\u201393. https:\/\/doi.org\/10.1172\/JCI41072.","journal-title":"J Clin Invest"},{"issue":"2","key":"4177_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbmt.2013.11.018","volume":"20","author":"H Sugiyama","year":"2014","unstructured":"Sugiyama H, Maeda Y, Nishimori H, Yamasuji Y, Matsuoka K, Fujii N, et al. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(2):183\u201391. https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.018.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"4177_CR76","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365(22):2055\u201366. https:\/\/doi.org\/10.1056\/NEJMoa1108188.","journal-title":"N Engl J Med"},{"issue":"7","key":"4177_CR77","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1172\/JCI39165","volume":"120","author":"S Asakura","year":"2010","unstructured":"Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, et al. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. J Clin Invest. 2010;120(7):2370\u20138. https:\/\/doi.org\/10.1172\/JCI39165.","journal-title":"J Clin Invest"},{"issue":"10","key":"4177_CR78","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2(10):1001\u201312. https:\/\/doi.org\/10.1038\/s42255-020-00280-9.","journal-title":"Nat Metab"},{"issue":"8","key":"4177_CR79","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41590-025-02223-6","volume":"26","author":"P Sharma","year":"2025","unstructured":"Sharma P, Guo A, Poudel S, Boada-Romero E, Verbist KC, Palacios G, et al. Early methionine availability attenuates T cell exhaustion. Nat Immunol. 2025;26(8):1384\u201396. https:\/\/doi.org\/10.1038\/s41590-025-02223-6.","journal-title":"Nat Immunol"},{"issue":"5","key":"4177_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood.2023019875","volume":"142","author":"H Senjo","year":"2023","unstructured":"Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, et al. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023;142(5):477\u201392. https:\/\/doi.org\/10.1182\/blood.2023019875.","journal-title":"Blood"},{"issue":"12","key":"4177_CR81","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314(12):729\u201335. https:\/\/doi.org\/10.1056\/NEJM198603203141201.","journal-title":"N Engl J Med"},{"issue":"1","key":"4177_CR82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1182\/blood.V68.1.119.119","volume":"68","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood. 1986;68(1):119\u201325.","journal-title":"Blood"},{"issue":"6","key":"4177_CR83","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96(6):2062\u20138.","journal-title":"Blood"},{"issue":"2","key":"4177_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;28(2):181\u20135. https:\/\/doi.org\/10.1038\/sj.bmt.1703097.","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"4177_CR85","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1182\/blood.V77.7.1423.1423","volume":"77","author":"A Bacigalupo","year":"1991","unstructured":"Bacigalupo A, Van Lint MT, Occhini D, Gualandi F, Lamparelli T, Sogno G, et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood. 1991;77(7):1423\u20138.","journal-title":"Blood"},{"issue":"13","key":"4177_CR86","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1182\/blood.v98.13.3868","volume":"98","author":"E Kansu","year":"2001","unstructured":"Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, et al. Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial. Blood. 2001;98(13):3868\u201370. https:\/\/doi.org\/10.1182\/blood.v98.13.3868.","journal-title":"Blood"},{"issue":"3","key":"4177_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa2503189","volume":"393","author":"DJ Curtis","year":"2025","unstructured":"Curtis DJ, Patil SS, Reynolds J, Purtill D, Lewis C, Ritchie DS, et al. Graft-versus-Host disease prophylaxis with cyclophosphamide and cyclosporin. N Engl J Med. 2025;393(3):243\u201354. https:\/\/doi.org\/10.1056\/NEJMoa2503189.","journal-title":"N Engl J Med"},{"issue":"1","key":"4177_CR88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181560","volume":"142","author":"H Senjo","year":"2023","unstructured":"Senjo H, Hashimoto D, Okada S, Kubota S, Ito A, Tanaka T, et al. Delayed initiation of calcineurin inhibitor is critical for tolerance induction by posttransplant cyclophosphamide. Blood. 2023;142(1):2041. https:\/\/doi.org\/10.1182\/blood-2023-181560.","journal-title":"Blood"},{"issue":"26","key":"4177_CR89","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1182\/blood.2024027301","volume":"145","author":"KM Habenicht","year":"2025","unstructured":"Habenicht KM, Wanzek J, Bootz A, Schafer S, Vollmer L, Hiergeist A, et al. Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD. Blood. 2025;145(26):3178\u201388. https:\/\/doi.org\/10.1182\/blood.2024027301.","journal-title":"Blood"},{"issue":"8","key":"4177_CR90","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood.2024024540","volume":"145","author":"Y Kambara","year":"2025","unstructured":"Kambara Y, Fujiwara H, Yamamoto A, Gotoh K, Tsuji S, Kunihiro M, et al. Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease. Blood. 2025;145(8):881\u201396. https:\/\/doi.org\/10.1182\/blood.2024024540.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04177-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:08:45Z","timestamp":1782468525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04177-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4177"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04177-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}